http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6434a71962d76a464fd25df84318511f
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | J. Harrison Harrison |
| name | David J Harrison David. J. Harrison David J. Harrison |
| given-name | David J David David J. David. J. |
| organization-name | 2Scottish Collaboration On Translational Research into Renal Cell Cancer (SCOTRRCC).; 5School of Medicine, University of St. Andrews, United Kingdom. 1Quantitative and Digital Pathology, School of Medicine, University of St. Andrews, St. Andrews, UK. School of Medicine; University of St Andrews; St. Andrews; Fife; UK Centre for Inflammation Research, University of Edinburgh, Edinburgh, Scotland Brain Repair Group, School of Biosciences, Cardiff University, UK School of Medicine, University of St Andrews, North Haugh, St Andrews KY16 9TF, UK Global Health Economics Amgen, Thousand Oaks, CA Amgen Inc., Thousand Oaks, CA, USA. School of Medicine University of St Andrews St Andrews KY16 9TF United Kingdom; NuCana Plc Edinburgh EH12 9DT United Kingdom University of St Andrews, St Andrews, UK. Breakthrough Research Unit and Division of Pathology, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK Amgen Thousand Oaks California School of Medicine, University of St Andrews, Fife KY16 9TF, United Kingdom Quantitative and Digital Pathology, School of Medicine, University of St Andrews, St Andrews, KY16 9TF, UK; Digital Pathology Unit, Laboratory Medicine, Royal Infirmary of Edinburgh, Edinburgh, EH16 4SA, UK Amgen, Thousand Oaks, California. School of Medicine, University of St Andrews, North Haugh, St Andrews KY16 9TF, United Kingdom Leverhulme Centre for the Future of Intelligence, University of Cambridge, Cambridge CB2 1SB, UK; Department of History and Philosophy of Science, University of Cambridge, Cambridge CB2 3RH, UK Health Economics Director, Amgen Inc., Thousand Oaks, California. Department of Pathology, University of Edinburgh, Edinburgh, United Kingdom. Authors' Affiliations: 1Division of Pathology and Edinburgh Breakthrough Research Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom; and 2Roche Diagnostics GmbH, Penzberg, Germany School of Medicine University of St Andrews St Andrews UK School of MedicineUniversity of St AndrewsSt AndrewsUnited Kingdom Division of Pathology, Institute of Molecular Medicine, University of Edinburgh, Edinburgh, U.K. School of Medicine, University of St Andrews, St Andrews KY16 9TF, UK Edinburgh Urological Cancer Group University of Edinburgh Edinburgh UK; School of Medicine University of St Andrews St Andrews UK Amgen Inc., Thousand Oaks, CA Edinburgh Urological Cancer Group, University of Edinburgh, Western General Hospital, Edinburgh, EH4 2XU, UK; School of Medicine, Medical & Biological Sciences Building, University of St Andrews, St Andrews, KY16 9TF, UK Division of Pathology, Institute of Genetics and Molecular Medicine, The University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, UK Sir Alastair Currie CRC Laboratories, Molecular Medicine Centre, The University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, United Kingdom; Department of Pathology, The University of Edinburgh Medical School, Teviot Place, Edinburgh, EH8 9AG, United Kingdom; Medical Research Council Human Genetics Unit, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, United Kingdom; and Centre for Molecular and Cellular Biology, University of Queensland, St. Lucia, 4072,... 5School of Medicine, University of St Andrews, St Andrews, United Kingdom.; 6NuCana plc, Edinburgh, United Kingdom. School of Medicine, University of St Andrews, St Andrews, KY16 9TF, United Kingdom Centre for Plant Sciences, Leeds Institute for Plant Biotechnology and Agriculture, University of Leeds, Leeds LS2 9JT, U.K. Digital Pathology Unit Laboratory Medicine Royal Infirmary of Edinburgh UK; Systems Pathology School of Medicine University of St Andrews UK Department of Chemistry and Bioscience, Chalmers University of Technology, Box 462, 405 30 Göteborg, Sweden, and Department of Chemistry, University of Göteborg, Box 462, 405 30 Göteborg, Sweden Breakthrough Breast Cancer Research Unit and Brain Repair Group, School of Biosciences, Cardiff University, Cardiff, United Kingdom Systems Pathology, Medical and Biological Sciences Building, University of St. Andrews, North Haugh, St. Andrews, Fife KY16 9TF, U.K. 1Edinburgh Breakthrough Research Unit and Division of Pathology, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom and 2Roche Diagnostics GMBH, Penzberg, Germany School of Medicine, University of St. Andrews, UK. School of Medicine, University of St Andrews, St Andrews, Fife, KY16 9TF, UK Brain Repair Group, School of Biosciences, Cardiff University, Cardiff, UK School of Medicine, University of St Andrews, St Andrews KY16 9TF, UK.; Biomedical Sciences Research Complex, University of St Andrews, St Andrews, UK. School of Medicine University of St. Andrews St. Andrews UK Brain Repair Group, School of Biosciences Cardiff University Cardiff United Kingdom 1Edinburgh Breakthrough Research Unit and Division of Pathology, School of Medicine, University of St Andrews, North Haugh, St Andrews, United Kingdom MRC Centre for Inflammation ResearchThe University of EdinburghMedical School Edinburgh UK Global Health Economics Edinburgh Breakthrough Research Unit and Pathology, Cancer Research Centre, Crewe Road South, Edinburgh, EH4 2XR, UK. Department of Pathology, The University of Edinburgh, Medical School, Teviot Place, Edinburgh EH8 9AG, U.K. Department of PathologyUniversity of Edinburgh U.K. Quantitative and systems pathology, University of St Andrews, North Haugh, Fife, St Andrews, KY16 9TF, UK. david.harrison@st-andrews.ac.uk. Division of Pathology, University of Edinburgh Medical School, Edinburgh EH8 9AG Authors' Affiliations: 1Cancer Research Program, Garvan Institute of Medical Research; 2St. Vincent's Hospital Clinical School and 3Bioanalytical Mass Spectrometry Facility, University of New South Wales, Sydney, New South Wales, Australia; and 4Division of Pathology and Edinburgh Breakthrough Research Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom School of Medicine, University of St Andrews, St Andrews KY16 9TF, U.K.; NuCana Plc, Edinburgh EH12 9DT, U.K. Scottish Collaboration On Translational Research into Renal Cell Cancer (SCOTRRCC), Scotland, UK; School of Medicine, University of St Andrews, Fife, UK Department of PathologyUniversity Medical SchoolTeviot PlaceEdinburghScotlandU.K. School of Medicine, University of St Andrews, St Andrews, KY16 9TF, UK Brain Repair Group, Life Science Building, 3rd Floor, School of Biosciences, Cardiff University, Museum Avenue, Cardiff, UK Authors' Affiliations: 1Barts Cancer Institute, Queen Mary University of London; 2Experimental Cancer Medicine Centre, University College; 3The Institute of Cancer Research; 4Guys and St Thomas' Hospital; 5The Royal Free Hospital London, London; 6Edinburgh Urological Cancer Group, University of Edinburgh, Edinburgh; 7Astra Zeneca, Manchester; 8School of Medicine, University of St Andrews, Fife, United Kingdom; 9National Cancer Institute, Amsterdam, the Netherlands; and 10University of Ghent, Ghent, Belgium; Authors' Affiliations: 1Barts Cancer Institute, Queen Mary University of London; 2Experimental Cancer Medicine Centre, University College; 3The Institute of Cancer Research; 4Guys and St Thomas' Hospital; 5The Royal Free Hospital London, London; 6Edinburgh Urological Cancer Group, University of Edinburgh, Edinburgh; 7Astra Zeneca, Manchester; 8School of Medicine, University of St Andrews, Fife, United Kingdom; 9National Cancer Institute, Amsterdam, the Netherlands; and 10University of Ghent, Ghent, Belgium 1University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom and Breakthrough Breast Cancer Research Unit, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom.; School of Medicine, University of St Andrews, St Andrews Department of PathologyMedical SchoolUniversity of Edinburgh Edinburgh Scotland EH8 9AG United Kingdom Amgen Inc. Thousand Oaks CA Department of PathologyEdinburgh University Scotland United Kingdom Global Health Economics, Amgen, Inc., Thousand Oaks, CA Biomedicine Division, School of Biosciences, Cardiff University, Cardif CF10 3AX, UK Edinburgh Urological Cancer Group, University of Edinburgh, Western General Hospital, Edinburgh; School of Medicine, University of St. Andrews, United Kingdom cGlobal Health Economics, Amgen Inc., Thousand Oaks, CA, USA University of St Andrews, St Andrews, Fife, UK Department of Quantitative and Digital Pathology, School of Medicine, University of St Andrews, St Andrews, UK Princess Margaret Hospital, Windsor, Berkshire SL4 3SJ, UK Amgen Inc. Thousand Oaks California |
Incoming Links
Total number of triples: 341.